Apr 9, 2024 07:00AM
Mar 11, 2024 07:00AM
Jan 22, 2024 07:03AM
Jan 22, 2024 07:00AM
Jan 8, 2024 07:04AM
Jan 8, 2024 07:00AM
Jan 3, 2024 07:02AM ProMIS Neurosciences (PMN) Appoints Neil Warma as Interim Chief Executive Officer
Jan 3, 2024 07:00AM
Dec 20, 2023 07:01AM
Dec 20, 2023 07:00AM
Nov 20, 2023 07:00AM
Nov 14, 2023 04:30PM
Sep 8, 2023 07:00AM
Aug 21, 2023 04:12PM ProMIS Neurosciences (PMN) Prices $20.4M Share Financing at $1.88/sh
Aug 21, 2023 04:12PM
Aug 14, 2023 05:33PM
Jul 17, 2023 07:00AM
Jul 10, 2023 07:55AM
May 15, 2023 05:00PM
May 8, 2023 09:00AM
May 8, 2023 09:00AM ProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer’s Disease
Apr 25, 2023 05:00PM
Apr 25, 2023 05:00PM
Apr 24, 2023 07:30AM
Apr 24, 2023 07:30AM
Apr 24, 2023 07:30AM
Apr 10, 2023 07:30AM
Apr 10, 2023 07:30AM ProMIS Neurosciences Announces Submission of Investigational New Drug (IND) Application for Lead Antibody PMN310
Apr 10, 2023 07:30AM
Mar 29, 2023 08:31AM
Mar 29, 2023 08:30AM
Mar 29, 2023 08:30AM
Nov 8, 2022 06:16AM
Nov 4, 2022 04:29PM
Nov 1, 2022 05:10PM Form S-1 ProMIS Neurosciences

66,415 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All